Lab Test

Chloride, Sweat

Sweat Chloride (Gibson Cooke)

Test Codes

Antrim #17099, EPIC: LAB5852, SOFT: SWCL

Department

Special Chemistry

Instructions

  • Outpatient: Sweat Chloride testing must be scheduled through the Beaumont Appointment Center at 800-328-8542.
  • Inpatient: Sweat Chloride testing must be ordered in EPIC. The Special Testing Laboratory must be notified at 248-551-8044 when the test has been ordered.
  • The patient must be adequately hydrated for proper sweat collection.
  • Sweat should not be collected from patients in oxygen tents or on infants less than 48 hours old.

Specimen Collection Criteria

Collect: Sweat specimen using the Gibson Cooke method. (Minimum: 0.075 g)

Rejection Criteria

Sweat weighing less than 0.075 grams.

Specimens not collected and processed as indicated.

In-Lab Processing

Analyze specimen immediately.

Storage

Specimen Stability for Testing:

Room Temperature (20-26°C or 68-78.8°F): 4 hours
Refrigerated (2-8°C or 36-46°F): 72 hours
Frozen (-20°C/-4°F or below): Unacceptable

Specimen Storage in Department Prior to Disposal:

Specimens are discarded once analysis is complete.

Laboratory

Royal Oak Special Testing Laboratory

Performed

Wednesday.
Results available within one business day.

Reference Range


 Interpretation Result (mmol/L)  Comment 
 Normal  <30 CF unlikely
 Intermediate  30-59 Intermediate range - need further study to establish or rule out a CF diagnosis
 Possible CF  ≥60 Indicative of CF for individuals presenting with a positive newborn screen, clinical features consistent with CF, or a positive family history

Test Methodology

Coulometric Titration.

Interpretation

Sweat chloride values greater than 59 mmol/L are consistent with cystic fibrosis in an individual with clinical symptoms of the disease. Elevated values in an adult may not indicate the presence of cystic fibrosis, but may reflect carrier status for a CF gene. Test results may be normal in CF individuals with salt depletion. Sweat chloride results may be increased in a number of other conditions with symptoms distinct from cystic fibrosis, including untreated adrenal insufficiency, familial hypoparathyroidism, nephrogenic diabetes insipidus, hypothyroidism, alcoholic pancreatitis, and some cases of renal disease.

Clinical Utility

This test aids in the diagnosis of cystic fibrosis.

CPT Codes

89230
LOINC: 2077-6

Contacts

Last Updated

1/4/2023

Microtainer® and Vacutainer® are registered trademarks of Becton, Dickinson and Company.
UroVysion® is a registered trademark of Abbott Laboratories. ThinPrep® is a registered trademark of Hologic, Incorporated.